The American Society of Clinical Oncology (ASCO) has developed updated guideline recommendations on the use of bisphosphonates, medications that help strengthen the bone, in people with multiple myeloma. The new guideline will be published in the June 10 issue of the Journal of Clinical Oncology. [click link for full article]